West Pharmaceutical Services Inc.
General ticker "WST" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $23.6B
West Pharmaceutical Services Inc. does not follow the US Stock Market performance with the rate: -20.6%.
Estimated limits based on current volatility of 1.5%: low 324.96$, high 334.53$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends: last record date 2024-11-13, amount 0.21$ (Y0.25%)
- US accounted for 42.0% of revenue in the fiscal year ended 2023-12-31
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [316.12$, 457.10$]
- 2024-12-30 to 2025-12-30 estimated range: [353.68$, 501.58$]
Financial Metrics affecting the WST estimates:
- Positive: Non-GAAP EPS, $ of 8.08 > 2.29
- Positive: Operating profit margin, % of 23.16 > 19.51
- Negative: Industry operating profit margin (median), % of -12.70 <= 2.14
- Positive: Return on assets ratio (scaled to [-100,100]) of 13.42 > 7.10
- Negative: Industry operating cash flow per share per price (median), % of 0.50 <= 3.85
Short-term WST quotes
Long-term WST plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $2,823.70MM | $2,860.10MM | $2,918.40MM |
| Operating Expenses | $2,071.40MM | $2,126.10MM | $2,242.40MM |
| Operating Income | $752.30MM | $734.00MM | $676.00MM |
| Non-Operating Income | $-3.40MM | $-54.10MM | $22.00MM |
| Interest Expense | $7.20MM | $7.90MM | $9.00MM |
| R&D Expense | $52.80MM | $58.50MM | $68.40MM |
| Income(Loss) | $748.90MM | $679.90MM | $698.00MM |
| Taxes | $107.20MM | $114.70MM | $122.30MM |
| Other Income(Loss) | $20.10MM | $20.70MM | $17.70MM |
| Profit(Loss) | $661.80MM | $585.90MM | $593.40MM |
| Stockholders Equity | $2,335.40MM | $2,684.90MM | $2,881.00MM |
| Inventory | $378.40MM | $414.80MM | $434.70MM |
| Assets | $3,313.80MM | $3,616.80MM | $3,829.50MM |
| Operating Cash Flow | $584.00MM | $724.00MM | $776.50MM |
| Capital expenditure | $253.40MM | $284.60MM | $362.00MM |
| Investing Cash Flow | $-253.10MM | $-288.20MM | $-368.70MM |
| Financing Cash Flow | $-168.10MM | $-293.60MM | $-459.60MM |
| Earnings Per Share* | $8.90 | $7.88 | $7.99 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.